Ipramol Steri-Neb

Ipratropium bromide and Salbutamol, the active ingredients in Ipramol Steri‑Neb, are a combination bronchodilator presented as a nebulizer solution for inhalation use. They relieve bronchospasm in patients with chronic obstructive pulmonary disease (COPD) and asthma by relaxing airway smooth muscle. The formulation provides rapid onset of action and is indicated for acute episodes of bronchoconstriction.

GNH USA supplies Ipramol Steri‑Neb as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ipramol Steri‑Neb, a combination bronchodilator, acts on the airway smooth muscle to alleviate bronchospasm in obstructive lung diseases.

- COPD: reduces bronchoconstriction and improves airflow during acute exacerbations. - Asthma: relieves acute bronchospasm and facilitates breathing in asthma attacks. - Other respiratory bronchospasm: helps open airways in various conditions causing bronchoconstriction.

Ipramol Steri‑Neb may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Cough or throat irritation: mild discomfort during inhalation. - Dry mouth: reduced salivation after use. - Tremor: fine shaking of hands or limbs. - Headache: mild to moderate pain. - Palpitations: sensation of rapid heartbeat. - Nausea: occasional upset stomach.

Serious or Rare Side Effects: - Paradoxical bronchospasm: worsening of breathing difficulty. - Severe tachycardia or arrhythmia: rapid or irregular heart rhythm. - Angioedema or anaphylaxis: swelling of face, lips, or throat requiring emergency care.

When using Ipramol Steri‑Neb, certain precautions should be observed to ensure safe administration.

- Cardiac assessment: monitor heart rate and blood pressure in patients with cardiovascular disease. - Glaucoma caution: avoid use in patients with narrow‑angle glaucoma due to anticholinergic effects. - Diabetes monitoring: observe blood glucose levels as salbutamol may raise glucose. - Concomitant beta‑blockers: be aware that non‑selective beta‑blockers can diminish bronchodilator effect. - Hypersensitivity: discontinue if signs of allergic reaction appear. - Store below 25°C: keep in the original container, protect from moisture and light.

Ipramol Steri‑Neb can interact with several medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Non‑selective beta‑blockers: may antagonize the bronchodilator effect and precipitate bronchospasm. - MAO inhibitors: combined use can increase the risk of severe hypertension. - Other anticholinergic agents: may enhance anticholinergic side effects.

Moderate Interactions (Monitor Closely): - Diuretics: may potentiate hypokalemia caused by salbutamol. - Theophylline: concurrent use can increase risk of cardiac arrhythmias. - ACE inhibitors: may increase cough and bronchial irritation.